ELI LILLY AND COMPANY |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 225.3 CHF | -1.50% |
|
-58.28% | -58.28% |
| 01:54pm | Patients on weight-loss drugs should inform doctor before surgery, EU regulator says | RE |
| Jul. 11 | Health Care Up as Obesity-Drug Wars Continue -- Health Care Roundup | DJ |
Quotes 5-day view
Delayed Quote London S.E.| 2024-07-08 | 2024-07-09 | 2024-07-10 | 2024-07-11 | |
|---|---|---|---|---|
| Last | 0 CHF | 0 CHF | 0 CHF | 0 CHF |
| Volume | 977 | 925 | 1 224 | 1 097 |
| Change | +-NaN% | +-NaN% | +-NaN% | +-NaN% |
| Opening | 0.00 | 0.00 | 0.00 | 0.00 |
| High | 0.00 | 0.00 | 0.00 | 0.00 |
| Low | 0.00 | 0.00 | 0.00 | 0.00 |
Performance
| 1 day | -1.50% | ||
| 1 week | -58.28% | ||
| Current month | -58.28% | ||
| 1 month | -58.28% | ||
| 3 months | -58.28% | ||
| 6 months | -58.28% | ||
| Current year | -58.28% | ||
| 1 year | -8.02% | ||
| 3 years | +3.81% | ||
| 5 years | +102.52% | ||
| 10 years | +296.71% |
Volumes
marketsDaily volume
109
Estimated daily volume
175
Avg. Volume 20 sessions
927
Daily volume ratio
0.19
Avg. Volume 20 sessions CHF
208 862.74
Avg. Volume 20 sessions USD
233 404.11
Record volume 1
1 344 004
Record volume 2
700 000
Record volume 3
691 071
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CHF)
841 104 687 278
Capitalization (USD)
841 104 687 278
Net sales (USD)
34 124 100 000
Number of employees
43 000
Sales / Employee (USD)
793 584
Free-Float
99.8 %
Free-Float capitalization (CHF)
990 646 627 770
Free-Float capitalization (USD)
886 341 444 332
Average Daily Capital Traded
0%
Highs and lows
1 year
225.31
540.00
3 years
210.33540.00
5 years
108.90540.00
10 years
54.85540.00
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.50% | -58.28% | -58.28% | -8.02% | 841B | ||
| +0.50% | -0.13% | +39.34% | +88.14% | 625B | ||
| +0.18% | +2.75% | -4.49% | -5.63% | 360B | ||
| +1.31% | +2.48% | +18.30% | +18.65% | 327B | ||
| +1.05% | +3.70% | +9.64% | +25.33% | 300B | ||
| +1.26% | +1.62% | +15.58% | +19.55% | 242B | ||
| +1.28% | +4.03% | +18.42% | +18.18% | 227B | ||
| +1.06% | +5.08% | +12.87% | +45.22% | 174B | ||
| +1.09% | +3.47% | -0.45% | -20.43% | 162B | ||
| +0.04% | +3.20% | +4.56% | +0.22% | 127B | ||
| +1.77% | +5.08% | -13.63% | -8.08% | 87.17B | ||
| -0.90% | +1.72% | -20.58% | -35.10% | 82.6B | ||
| +1.03% | +0.66% | +4.88% | +14.21% | 79.27B | ||
| -0.66% | +4.12% | +54.62% | +57.97% | 72.57B | ||
| -1.10% | +1.35% | +17.63% | +66.42% | 65.94B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| Average | +0.31% | +2.72% | +6.56% | +18.44% | ||
| Weighted average by Cap. | +0.11% | +2.15% | -1.02% | +21.08% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2023 | +120.45% | ||
| 2022 | +8.72% | ||
| 2021 | +75.75% | ||
| 2020 | +1.71% | ||
| 2019 | +16.24% | ||
| 2018 | +31.91% | ||
| 2017 | +11.61% | ||
| 2016 | -13.67% | ||
| 2015 | +23.96% | ||
| 2014 | +51.42% | ||
| 2013 | +4.32% | ||
| 2012 | +12.51% | ||
| 2011 | +18.16% | ||
| 2010 | -11.82% | ||
| 2009 | -9.63% | ||
| 2008 | -33.46% | ||
| 2007 | -3.92% | ||
| 2005 | -0.75% | ||
| 2004 | -27.22% | ||
| 2003 | +0.24% | ||
| 2002 | -16.66% | ||
| 2001 | +2.44% | ||
| 2000 | +1.71% | ||
| 1999 | -17.30% | ||
| 1998 | +32.42% | ||
| 1997 | +298.25% | ||
| 1996 | +12.53% | ||
| 1995 | +51.99% | ||
| 1994 | -8.69% | ||
| 1993 | +0.88% | ||
| 1992 | -1.82% |
- Stock Market
- Equities
- LLY Stock
- LEL Stock
- Quotes Eli Lilly and Company
